NADPH氧化酶4在肾脏与心血管系统中的潜在获益与风险
该综述总结NADPH氧化酶4(NOX4)在肾脏与心血管系统中的双重作用。NOX4在肾小管细胞高表达,生理条件下持续产过氧化氢;糖尿病时足细胞和系膜细胞NOX4表达升高可损伤肾小球,而NOX4缺失小鼠更易发生急慢性肾小管损伤、心力衰竭和动脉粥样硬化。随着NOX4抑制剂进入临床试验,需警惕急性肾损伤和心血管病患者的潜在副作用。
要点
- 糖尿病肾病中足细胞和系膜细胞NOX4表达升高可致肾小球损伤。
- NOX4在肾小管细胞、心肌细胞和内皮细胞中具细胞保护作用。
- NOX4抑制剂临床试验需警惕急性肾损伤和心血管副作用。
核心结论
- NOX4在系膜细胞和足细胞表达升高时对糖尿病肾病有害,但在内源性表达的肾小管细胞、心肌细胞、内皮细胞和血管平滑肌细胞中具细胞保护作用。
研究设计与样本
- 综述汇总NOX4在肾脏与心血管系统中作用的近期证据,涉及NOX4缺陷小鼠实验及正在进行的NOX4抑制剂临床试验。
主要发现
- NOX4在肾小管细胞高表达,生理条件下持续产过氧化氢,其他NOX亚型主要产超氧阴离子。
- 糖尿病使足细胞和系膜细胞NOX4表达升高,导致足细胞丢失、系膜细胞肥大和基质积聚。
- 全身NOX4缺失小鼠更易发生急性和慢性肾小管损伤、心力衰竭和动脉粥样硬化。
临床怎么用
- NOX4抑制剂用于纤维化疾病和肾病治疗时,需警惕急性肾损伤和心血管病患者的潜在副作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The main function of NADPH oxidases is to catalyse the formation of reactive oxygen species (ROS). NADPH oxidase 4 (NOX4) is expressed at high levels in kidney tubular cells, and at lower levels in endothelial cells, cardiomyocytes and other cell types under physiological conditions. NOX4 is constitutively active producing hydrogen peroxide (H2O2) as the prevalent ROS detected, whereas other NOX isoforms present in the renal and cardiovascular systems (i.e. NOX1, NOX2 and NOX5) generate superoxide radical anions as main products. Pharmacological inhibition of NOX4 has received enormous attention for its potential therapeutic benefit in fibrotic disease and nephropathologies. Ongoing clinical trials are testing this approach in humans. Diabetes elevates NOX4 expression in podocytes and mesangial cells, which was shown to damage glomeruli leading to podocyte loss, mesangial cell hypertrophy and matrix accumulation. Consequently, NOX4 represents an interesting therapeutic target in diabetic nephropathy. On the contrary, experiments using NOX4-deficient mice have shown that NOX4 is cytoprotective in tubular cells, cardiomyocytes, endothelial cells and vascular smooth muscle cells, and has a metabolism-regulating role when these cells are subjected to injury. Mice with systemic NOX4 deletion are more susceptible to acute and chronic tubular injury, heart failure and atherosclerosis. Overall, the current literature suggests a detrimental role of increased NOX4 expression in mesangial cells and podocytes during diabetic nephropathy, but a cytoprotective role of this enzyme in other cellular types where it is expressed endogenously. We review here the recent evidence on the role of NOX4 in the kidneys and cardiovascular system. With the emergence of pharmacological NOX4 inhibitors in clinical trials, caution should be taken in identifying potential side effects in patients prone to acute kidney injury and cardiovascular disease.
引用
- Rajaram RD, Dissard R, Jaquet V, et al. Potential benefits and harms of NADPH oxidase type 4 in the kidneys and cardiovascular system. Nephrol Dial Transplant. 2019. PMID: 29931336. doi:10.1093/ndt/gfy161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。